STEM CELL THERAPY AND NEUROGENESIS: A THERAPEUTIC VIABILITY IN ALZHEIMER’S DISEASE

Author(s): Shaina Thakur, Pulkit Rajan, Shbham Sharma, Oshina, Pratyancha Sharma, Shalu Sharma and Vivek Sharma*

Abstract: Neurodegenerative diseases result from a temporally discrete insult (stroke, trauma), aggregation of proteins, aging and any untoward injury leading to loss of a particular neuronal subtype or generalized loss of neuronal populations. Alzheimer’s disease (AD) is a chronic, intricate, irreversible, dynamic neurodegenerative sickness which affects 5–7% of older adults globally, the number of AD cases currently estimated at 36 million and will triple by 2050.

PAGES: 867-873  |  73 VIEWS  253 DOWNLOADS